The 25% increase in the numeric value of a metric that helps decide whether pharmaceuticals are worth the cost isn’t the same as a 25% hike in the price of new drugs.
The 25% increase in the numeric value of a metric that helps decide whether pharmaceuticals are worth the cost isn’t the same as a 25% hike in the price of new drugs.